Results of Open-label Extension of the ORIGIN Study – Explore the Visual Abstract
This visual abstract was supported by Vera Therapeutics.
09Dec
Share
Back to News
Back to News
Related Posts
24Mar
ISN Journal summaries on CKD-MBD, Pexivas trial, in-center hemodialysis, and the ISN Collaborative Quality Framework on Dialysis
Kidney International® (KI) Chronic Kidney Disease–Mineral and Bone Disorder: Conclusions From a... read more
24Mar
New specialized ISN Fellowship opportunity in glomerular disease training
The ISN has joined forces with Otsuka Pharmaceutical to support specialized... read more
24Mar
ISN Young Nephrologists – win free registration to the 43rd Vicenza Course: Apply by April 15
The 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology 2025 takes place June... read more
24Mar
Optimize trial integrity: New SOP and ethics resources in the ISN-ACT Clinical Trials Toolkit
The ISN-ACT Toolkit now features a section on Standard Operating Procedures (SOPs) in... read more
24Mar
Share knowledge, build connections – apply to become an ISN mentor by April 1
ISN Mentorships foster meaningful connections between experienced nephrologists and early-career professionals,... read more
24Mar
New, upgraded, and graduated ISN Sister Renal Centers partnerships: Thank you to our supporters!
The ISN Sister Renal Centers (SRC) Committee is pleased to welcome... read more
24Mar
ISN Educational Ambassador strengthens interventional nephrology in India
ISN Educational Ambassador (EA) and former ISN Fellow Shahbaj Ahmad, a... read more
24Mar
“Highly enriching”: Expanding expertise with ISN Renal Pathology Bursaries
Ehab Hafiz from the Theodor Bilharz Research Institute in Giza, Egypt,... read more
24Mar
Share your AI expertise in nephrology at the ISN Academy – apply now!
The ISN Academy is launching a new series featuring artificial intelligence... read more
24Mar
Enhance patient care with cardio-kidney-metabolic resources
Are you making the most of the latest clinical tools from... read more
24Mar
ISN Journal summaries on CKD-MBD, Pexivas trial, in-center hemodialysis, and the ISN Collaborative Quality Framework on Dialysis
Kidney International® (KI) Chronic Kidney Disease–Mineral and Bone Disorder: Conclusions From a... read more
24Mar
New specialized ISN Fellowship opportunity in glomerular disease training
The ISN has joined forces with Otsuka Pharmaceutical to support specialized... read more
24Mar
ISN Young Nephrologists – win free registration to the 43rd Vicenza Course: Apply by April 15
The 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology 2025 takes place June... read more
24Mar
Optimize trial integrity: New SOP and ethics resources in the ISN-ACT Clinical Trials Toolkit
The ISN-ACT Toolkit now features a section on Standard Operating Procedures (SOPs) in... read more
24Mar
Share knowledge, build connections – apply to become an ISN mentor by April 1
ISN Mentorships foster meaningful connections between experienced nephrologists and early-career professionals,... read more
24Mar
New, upgraded, and graduated ISN Sister Renal Centers partnerships: Thank you to our supporters!
The ISN Sister Renal Centers (SRC) Committee is pleased to welcome... read more
24Mar
ISN Educational Ambassador strengthens interventional nephrology in India
ISN Educational Ambassador (EA) and former ISN Fellow Shahbaj Ahmad, a... read more
24Mar
“Highly enriching”: Expanding expertise with ISN Renal Pathology Bursaries
Ehab Hafiz from the Theodor Bilharz Research Institute in Giza, Egypt,... read more
24Mar
Share your AI expertise in nephrology at the ISN Academy – apply now!
The ISN Academy is launching a new series featuring artificial intelligence... read more
24Mar
Enhance patient care with cardio-kidney-metabolic resources
Are you making the most of the latest clinical tools from... read more